Satsuma Pharmaceuticals

Home » Satsuma Pharmaceuticals

IPO

Satsuma Pharmaceuticals

Pharmaceutical

We are a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine.

Symbol

STSA

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
September 13, 2019

Underwriters
CREDIT SUISSE SECURITIES (USA) LLC ,LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for Satsuma Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253